Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
09/2009
09/15/2009CA2218699C 1,3-propane diol derivatives as bioactive compounds
09/11/2009WO2009110520A1 Heterocyclic compound
09/11/2009WO2009109483A1 Leukotriene b4 inhibitors
09/11/2009WO2009078981A3 Ppar-delta ligands and methods of their use
09/11/2009WO2009068463A3 Process for the preparation of isoindole derivatives as well as a process for the preparation of their intermediates
09/11/2009WO2009015067A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/11/2009WO2008157740A3 Faah inhibitors
09/11/2009WO2008097938A3 Indole polymorphs
09/11/2009CA2717202A1 Leukotriene b4 inhibitors
09/10/2009US20090227789 Ethylenediamine derivatives
09/10/2009US20090227765 Monomer for making a crosslinked polymer
09/10/2009US20090227652 Indole derivatives and methods of using the same
09/10/2009US20090227603 Leukotriene b4 inhibitors
09/10/2009US20090227585 Substituted n-heterocycle derivatives and methods of their use
09/10/2009US20090227571 Androgen Receptor Modulator Compounds and Methods
09/10/2009US20090227538 N-(Hetero)Aryl Indole Derivatives as Pesticides
09/09/2009EP2098507A1 Cyclic amine compound
09/09/2009EP2097375A1 Method for purifying bisimides
09/09/2009EP2097374A2 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors
09/09/2009EP2097373A1 Sulfonamide derivatives as liver carnitine palmitoyl transferase (l-cptl )
09/09/2009EP2016050B1 A process for the purification of ropinirole hydrochloride
09/09/2009EP1856045B1 1-acetic acid-indole derivatives with pgd2 antagonist activity
09/09/2009EP1449833B1 Bisimide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition
09/09/2009CN101528694A Oxime ester compound and photopolymerization initiator containing the compound
09/09/2009CN101528693A Oxime ester compound, photopolymerization initiator, photopolymerizable composition, color filter, and liquid crystal display device
09/09/2009CN101528692A Novel compounds and compositions thereof
09/09/2009CN101528691A Matrix metalloproteinase inhibitors
09/09/2009CN101528690A Isoindoline derivatives for the treatment of arrhythmias
09/09/2009CN101528689A Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
09/09/2009CN101528688A Chemical process
09/09/2009CN100539202C Photoelectric conversion device
09/09/2009CN100537527C Aryl and biaryl compounds having MCH modulatory activity
09/08/2009US7585982 Methods for producing isoindole derivatives
09/08/2009US7585981 electrostatic shields, capacitors, cells, EMI shielding agents, chemical sensors, display elements, prevention of electrification, antirust agents, adhesives, textiles, antistatic paints; produced by oxidizing an indole derivative in a reaction solution containing an organic solvent
09/08/2009US7585976 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting
09/08/2009US7585974 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application
09/08/2009US7585925 Method of producing a polymer network
09/08/2009US7585885 Beta -secretase (BACE); Alzheimer's disease; 2-(R)-[2-(S)-Amino-3-(3,5-difluorophenyl)-1-(S)-hydroxypropyl]-pyrrolidine-1-carboxylic acid tert-butyl ester
09/08/2009US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder
09/08/2009CA2520901C Pyrene-linked pyrrolo (2,1-c) (1,4) benzodiazepine derivatives useful as anticancer agents
09/08/2009CA2440931C Hiv protease inhibitors based on amino acid derivatives
09/08/2009CA2335623C Aminoiminoquinone and aminoquinine alkaloid compounds as capase inhibitors
09/08/2009CA2316388C Tetrahydrobenzindole derivative
09/08/2009CA2314339C N-benzyl-3-indenylacetamide derivatives for treating neoplasia
09/03/2009WO2009107769A1 Reagent for measurement of reactive oxygen
09/03/2009WO2009107762A1 Aromatic amide derivative
09/03/2009WO2009106307A1 Substituted 4-aminocyclohexane derivatives for the treatment of pain
09/03/2009WO2009080799A3 Carbazole-based hole transport and /or electron blocking materials and /or host polymer materials
09/03/2009WO2009053754A3 Novel crystalline forms
09/03/2009WO2009053733A3 Novel crystalline forms
09/03/2009US20090221817 Triethylamine was added dropwise to a solution of 2-methylpropane-2-sulfinyl chloride and methyl trans-4-amino-1-cyclohexane carboxylate p-toluenesulfonate in tetrahydrofuran solvent to obtain Methyl trans-4-(2-methylpropane-2-sulfonylamino)cyclohexanecarboxylate; hydrolysis; oxidation; intermediates
09/03/2009US20090221614 Selective serine/threonine kinase inhibitors
09/03/2009US20090221575 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
09/03/2009US20090221527 Tumor necrosis factor inhibitors
09/03/2009US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy
09/03/2009US20090220420 Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (pbr)
09/03/2009CA2716613A1 Substituted 4-aminocyclohexane derivatives for the treatment of pain
09/02/2009EP2096109A1 Carboxylic acid derivative
09/02/2009EP2096104A1 Organic diamines as mGluR7 modulators
09/02/2009EP2095875A1 Homogeneous asymmetric hydrogenation catalyst
09/02/2009EP2094662A1 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents
09/02/2009EP2094658A2 Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
09/02/2009EP2094657A1 Azabicyclic compounds as serotonine, dopamine and norepinephrine re-uptake inhibitors
09/02/2009EP2094649A2 Materials and methods for co-crystal controlled solid-state synthesis of imides and imines
09/02/2009EP2094646A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases
09/02/2009EP1660559B1 Novel approach to reduce cyclics formation in the production of polyetherimides
09/02/2009CN101522618A 3-aza-bicyclo[3.1.0]hexane derivatives
09/02/2009CN101522617A Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
09/02/2009CN101522616A Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
09/02/2009CN101522615A Vinylogous acids derivatives as chymase inhibitors
09/02/2009CN101522614A Novel compounds as antagonists or inverse agonists at opioid receptors
09/02/2009CN101519372A Benzo [e] isoindazole-1,3 diketone compound used as GSK inhibiting agent and preparation method thereof
09/02/2009CN101519368A Small molecule entry inhibitors
09/02/2009CN101519335A Method for improving selectivity of heterogeneous asymmetric catalytic reaction enantiomer
09/01/2009US7582774 reacting hydroxyamine with succinic anhydride, or succinic acid to produce N-hydroxysuccinimide; using solvent undergoing azeotropy with water while carrying out dewatering; oxidizing agents for use photography developers, reagents for synthetically preparing peptides; intermediates for insecticides
09/01/2009US7582773 Thrombosis; antiischemic agents; chronic obstructive pulmonary disease; antidiabetic agents; antiarthritic agents ; Alzheimer's disease; anticancer agents; strokes; cardiovascular disorders
09/01/2009US7582772 producing 4-{3-[1-benzhydryl-5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoic acid (efipladib); cost effective of using less palladium catalyst
09/01/2009US7582771 Process for the synthesis of cPLA2 inhibitors
09/01/2009US7582770 3-(2-{1-[(3-Cyclopentyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carbonyl)amino]cyclobutyl}-1-methyl-1H-benzoimidazol-5-yl)acrylic acid; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
09/01/2009US7582672 Compounds for the treatment of CRTH2-mediated diseases and conditions
09/01/2009US7582671 Therapeutic use of N-(1H-indolyl)-1H-indole-2-carboxamide derivatives
09/01/2009US7582657 Vanilloid receptor ligands and their use in treatments
09/01/2009CA2490115C Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
08/2009
08/27/2009WO2009105722A1 Compounds and compositions as modulators of gpr119 activity
08/27/2009WO2009104488A1 White light-emitting organic electroluminescent device
08/27/2009WO2009103875A1 Novel diazeniumdiolate derivatives, method for the preparation thereof and pharmaceutical compositions containing the same
08/27/2009WO2009103710A1 Substituted 4-hydroxy-n- (4-hydroxyphenyl) indoles as estrogenic agents
08/27/2009WO2009103218A1 Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof
08/27/2009WO2009086028A3 Carbazole-containing materials in phosphorescent light emitting diodes
08/27/2009WO2009071957A3 Novel peptides and amino acid derivatives, pharmaceutical compositions containing same and the use of these compounds
08/27/2009WO2009066035A3 Combination between an anti-atherothrombotic and an angiotensin-converting enzyme inhibitor
08/27/2009WO2009050410A3 Carbene and co<sb>2</sb> adducts and use thereof for co<sb>2</sb> extraction
08/27/2009WO2009026248A3 Hydrazide, amide, phthalimide and phthalhydrazide analogs as inhibitors of retroviral integrase
08/27/2009WO2007003934A3 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors
08/27/2009US20090216023 e.g.2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-(pyrimidine or pyridazine or piperazine)-pyrrole-5-carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive
08/27/2009US20090215958 Conducting polymers and uses thereof
08/27/2009US20090215814 Method of inhibiting neurotrophin-receptor binding
08/27/2009US20090215795 Cyclic amidine derivatives
08/27/2009US20090215772 Hydroxybenzamide derivatives and their use as inhibitors of HSP90
08/27/2009US20090215742 Amide resorcinol compounds